CAS: 1338934-59-0
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | MKC8866 REF: TM-T15594CAS: 1338934-59-0 | 99.28% - 99.35% | 88.00 €~2,024.00 € | Wed 11 Dec 24 |
 | MKC8866 REF: IN-DA01EOOWCAS: 1338934-59-0 | 99% | To inquire | Wed 11 Dec 24 |
 | MKC8866 REF: 3D-NDC93459CAS: 1338934-59-0 | Min. 95% | 164.00 €~2,019.00 € | Fri 27 Dec 24 |
MKC8866
CAS:1338934-59-0
MKC8866, a selective IRE1 RNase inhibitor with an IC50 of 0.29 μM, curbs breast and …
Formula:
C18H19NO7
Purity:
99.28% - 99.35%
Color and Shape:
Solid
Molecular weight:
361.35
Ref: TM-T15594
| 1mg | 88.00 € | ||
| 5mg | 187.00 € | ||
| 10mg | 304.00 € | ||
| 25mg | 511.00 € | ||
| 50mg | 739.00 € | ||
| 100mg | 1,034.00 € | ||
| 500mg | 2,024.00 € |
Estimated delivery in United States, on Wednesday 11 Dec 2024
Ref: IN-DA01EOOW
| 1mg | 61.00 € | ||
| 5mg | 112.00 € | ||
| 10mg | 185.00 € | ||
| 25mg | 264.00 € | ||
| 50mg | 593.00 € | ||
| 100mg | To inquire | ||
| 250mg | To inquire |
Estimated delivery in United States, on Wednesday 11 Dec 2024
MKC8866
CAS:1338934-59-0
MKC8866 is an experimental anti-cancer drug that is currently in Phase II clinical trials. It …
Formula:
C18H19NO7
Purity:
Min. 95%
Color and Shape:
Powder
Molecular weight:
361.35 g/mol
Ref: 3D-NDC93459
| 1mg | 164.00 € | ||
| 2mg | 280.00 € | ||
| 5mg | 556.00 € | ||
| 10mg | 954.00 € | ||
| 25mg | 2,019.00 € |
Estimated delivery in United States, on Friday 27 Dec 2024
